Literature DB >> 31246727

Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity.

Diane Marcé1, Hélène Cornillier1, Christelle Denis2, Annie-Pierre Jonville-Bera3, Laurent Machet1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31246727     DOI： 10.1097/CMR.0000000000000600

Source DB:  PubMed          Journal:  Melanoma Res        ISSN： 0960-8931            Impact factor:   3.599


× No keyword cloud information.
  2 in total

1.  MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy.

Authors:  Silke Schrom; Thomas Hebesberger; Stefanie Angela Wallner; Ines Anders; Erika Richtig; Waltraud Brandl; Birgit Hirschmugl; Mariangela Garofalo; Claudia Bernecker; Peter Schlenke; Karl Kashofer; Christian Wadsack; Ariane Aigelsreiter; Ellen Heitzer; Sabrina Riedl; Dagmar Zweytick; Nadine Kretschmer; Georg Richtig; Beate Rinner
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 2.  Melanoma in pregnancy: certainties unborn.

Authors:  Enrico Zelin; Claudio Conforti; Roberta Giuffrida; Teresa Deinlein; Nicola di Meo; Iris Zalaudek
Journal:  Melanoma Manag       Date:  2020-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.